Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity
Hao Zheng(Nanchang University), Bo Liang(University of Chinese Academy of Sciences), Yuan‐Ping Tao(Ministry of Education), Bo-ning Chen(Nanchang University), Daimin Xiang(Second Military Medical University), Yi-nuo Zhang(Nanchang University), Fang Lü(Hunan Normal University), Le Yang(Guangzhou University of Chinese Medicine), Wen-juan Zheng(Nanchang University), Liu Ouyang(Hubei University of Medicine), Zhiping Huang(General Hospital of Guangzhou Military Command), Zhiqing Duan(Nanchang University), Fan Zhou(Sichuan University), Zhenguang Wang(Beijing Institute of Technology), Gang Jin(Second Military Medical University)
Cited by 9
Related Papers
N6-Methyladenosine–Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells’ Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways
|Gastroenterology|2023|272
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors
|Cellular and Molecular Immunology|2021|254
Antiviral Therapy Improves Postoperative Survival in Patients With Hepatocellular Carcinoma
|Annals of Surgery|2014|229
Waist Circumference, Waist: Hip Ratio, and Risk of Breast Cancer in the Nurses' Health Study
|American Journal of Epidemiology|1999|225